ALS market across 8MM set to reach $1.28 bn in 2029: GlobalData GlobalData Jun 13, 2024 The prevalence of ALS is increasing at a steady rate, in line with population growth in the 8MM, at an AGR of 0.79 per cent
Biogen, Ionis terminates development of ALS investigational drug EP News Bureau May 17, 2024 Topline results from the Phase 1/2 ALSpire study indicated no reduction in levels of plasma neurofilament light chain (NfL), a…
